Arturo Molina

Arturo Molina

Company: Sutro Biopharma

Job title: Chief Medical Officer

Seminars:

Live Discussion & Question Time 5:20 pm

Read more

day: Day Two

Treatment of Ovarian & Endometrial Cancer with the Novel Folate Receptor-α-targeting Antibody Drug Conjugate, STRO-002 4:00 pm

Optimising linker-warhead and site-specific conjugation to produce a homogeneous product and improve therapeutic index Preclinical rationale for STRO-002 in cell line, xenograft and PDX studies Dose-escalation study and recommended Phase 2 dose Dose expansion and registration-directed clinical development studiesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.